Efficacy of Intraarticular Vancomycin in Preventing Infection in Patients Undergoing Hip Hemiarthroplasty

Overview

Journal Galen Med J

Specialty General Medicine

Date 2024 Oct 30

PMID 39474585

Authors

Payam Mohammadhoseini

Seyed Mohammad Mohammadi

Amir Aghaei Aghdam

Mohsen Asgari

Affiliations

Soon will be listed here.

Abstract

Background: Hip fractures are among the top ten causes of disability in adults worldwide. Patients with hip fracture are at significant risk of mortality and morbidity and reduced quality of life. The use of intra-wound vancomycin has been reported to be effective in reducing the incidence of infection in orthopedic surgeries. This study was conducted with the aim of investigating the effect of intra-articular vancomycin in preventing infection in patients undergoing hip hemiarthroplasty.

Materials And Methods: This double-blind controlled clinical trial study was conducted on 48 patients with femoral neck fracture candidates for hip hemiarthroplasty hemiarthroplasty in Orthopedic clinic of Golestan and Imam Khomeini Hospital, Ahvaz, Iran between June and November 2023. Eligible patients were divided into two equal groups. The intervention group received 1gram vancomycin intra-articularly during the operation before closure of fascia, and the control group did not receive vancomycin. The patients were followed up for 6 months after the operation, and the rate of superficial infection, periprosthetic joint infection (PJI) and wound complications were compared in two groups. The obtained data were statistically analyzed with IBM SPSS Statistics 21.0 for Windows.

Results: The vancomycin group and the control group had no significant difference in the incidence of overall infection. The PJI in vancomycin and control groups were 4.16% and 8.33%, respectively. This difference was not statistically considerable (P=0.55). The results showed the incidence of superficial estimated 8.33% in vancomycin group and 4.16% in control group with no considerable difference in infection (P=0.52). Moreover, there was no meaningful difference in side effects between the two groups (P=0.63). There was no significant difference in wound complications between the two groups (P=0.3). After the intervention, it was found that the ESR value in the control group and vancomycin group was 32.79±9.94, 31.83±9.78 mm/hr, respectively (P=0.73).

Conclusion: Intra-articular injection of 1gram of vancomycin suspension did not reduce the overall, superficial and deep infection after surgery. It is suggested that more clinical trial studies with higher sample size be conducted in order to determine the effect of intra-articular vancomycin in preventing infection in patients undergoing hip hemiarthroplasty.

References

Lovallo J, Murray R, Wiesel B, Curley A, Conroy C, Johnson D . Intraoperative Intra-articular Antibiotic Injection Reduces Infection in Shoulder Arthroplasty. Orthopedics. 2023; 46(5):310-314. DOI: 10.3928/01477447-20230224-06. View

Dial B, Lampley A, Green C, Hallows R . Intrawound Vancomycin Powder in Primary Total Hip Arthroplasty Increases Rate of Sterile Wound Complications. Hip Pelvis. 2018; 30(1):37-44. PMC: 5861024. DOI: 10.5371/hp.2018.30.1.37. View

Xu H, Yang J, Xie J, Huang Z, Huang Q, Cao G . Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty. Bone Joint Res. 2020; 9(11):778-788. PMC: 7649508. DOI: 10.1302/2046-3758.911.BJR-2020-0190.R2. View

Hanada M, Nishikino S, Hotta K, Furuhashi H, Hoshino H, Matsuyama Y . Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties. Knee Surg Sports Traumatol Arthrosc. 2019; 27(7):2322-2327. DOI: 10.1007/s00167-019-05498-z. View

Murphy E, Spencer S, Young D, Jones B, Blyth M . MRSA colonisation and subsequent risk of infection despite effective eradication in orthopaedic elective surgery. J Bone Joint Surg Br. 2011; 93(4):548-51. DOI: 10.1302/0301-620X.93B4.24969. View

Mamarelis G, Key S, Snook J, Aldam C . Outcomes after early return to theatre following hip hemiarthroplasty for intracapsular fracture of the femoral neck. Bone Joint J. 2017; 99-B(7):958-963. DOI: 10.1302/0301-620X.99B7.BJJ-2016-0890.R1. View

Heckmann N, Mayfield C, Culvern C, Oakes D, Lieberman J, Della Valle C . Systematic Review and Meta-Analysis of Intrawound Vancomycin in Total Hip and Total Knee Arthroplasty: A Call for a Prospective Randomized Trial. J Arthroplasty. 2019; 34(8):1815-1822. DOI: 10.1016/j.arth.2019.03.071. View

Lora-Tamayo J, Euba G, Ribera A, Murillo O, Pedrero S, Garcia-Somoza D . Infected hip hemiarthroplasties and total hip arthroplasties: Differential findings and prognosis. J Infect. 2013; 67(6):536-44. DOI: 10.1016/j.jinf.2013.07.030. View

Burns A, Chao T, Tsai N, Lynch J, Smith P . The use of intra-articular vancomycin is safe in primary hip and knee arthroplasty. J Orthop. 2023; 46:161-163. PMC: 10663633. DOI: 10.1016/j.jor.2023.10.017. View

10.

Norton T, Skeete F, Dubrovskaya Y, Phillips M, Bosco 3rd J, Mehta S . Orthopedic surgical site infections: analysis of causative bacteria and implications for antibiotic stewardship. Am J Orthop (Belle Mead NJ). 2014; 43(5):E89-92. View

11.

Hey H, Thiam D, Koh Z, Thambiah J, Kumar N, Lau L . Is Intraoperative Local Vancomycin Powder the Answer to Surgical Site Infections in Spine Surgery?. Spine (Phila Pa 1976). 2017; 42(4):267-274. DOI: 10.1097/BRS.0000000000001710. View

12.

Xu X, Zhang X, Zhang Y, Chen C, Yu H, Xue E . Role of intra-wound powdered vancomycin in primary total knee arthroplasty. Orthop Traumatol Surg Res. 2020; 106(3):417-420. DOI: 10.1016/j.otsr.2020.01.007. View

13.

Matziolis G, Brodt S, Bohle S, Kirschberg J, Jacob B, Rohner E . Intraarticular vancomycin powder is effective in preventing infections following total hip and knee arthroplasty. Sci Rep. 2020; 10(1):13053. PMC: 7400548. DOI: 10.1038/s41598-020-69958-0. View

14.

Buchalter D, Teo G, Kirby D, Schwarzkopf R, Aggarwal V, Long W . Does the Organism Profile of Periprosthetic Joint Infections Change With a Topical Vancomycin Powder and Dilute Povidone-Iodine Lavage Protocol?. J Arthroplasty. 2021; 36(7S):S314-S319. DOI: 10.1016/j.arth.2020.12.036. View

15.

Bhandari M, Einhorn T, Guyatt G, Schemitsch E, Zura R, Sprague S . Total Hip Arthroplasty or Hemiarthroplasty for Hip Fracture. N Engl J Med. 2019; 381(23):2199-2208. DOI: 10.1056/NEJMoa1906190. View

16.

Wang F, Zhou H, Olademehin O, Kim S, Tao P . Insights into Key Interactions between Vancomycin and Bacterial Cell Wall Structures. ACS Omega. 2018; 3(1):37-45. PMC: 5793038. DOI: 10.1021/acsomega.7b01483. View

17.

Kurtz S, Lau E, Schmier J, Ong K, Zhao K, Parvizi J . Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008; 23(7):984-91. DOI: 10.1016/j.arth.2007.10.017. View

18.

Erken H, Nusran G, Karaguven D, Yilmaz O, Kuru T . No Decrease in Infection Rate with the Use of Local Vancomycin Powder After Partial Hip Replacement in Elderly Patients with Comorbidities. Cureus. 2020; 12(9):e10296. PMC: 7540078. DOI: 10.7759/cureus.10296. View

19.

Kim S, Cho Y . Current Guideline for Diagnosis of Periprosthetic Joint Infection: A Review Article. Hip Pelvis. 2021; 33(1):11-17. PMC: 7952269. DOI: 10.5371/hp.2021.33.1.11. View

20.

Guren E, Figved W, Frihagen F, Watne L, Westberg M . Prosthetic joint infection-a devastating complication of hemiarthroplasty for hip fracture. Acta Orthop. 2017; 88(4):383-389. PMC: 5499328. DOI: 10.1080/17453674.2017.1301009. View